from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2853/PE_PGRS48

LFCtreatmentdescriptionclass of inhibitor

0.338

Amikacinug/mL Amikacintranslation

-0.335

Cap5-10ug/mL Capreomycintranslation

-0.676

Rox10-50 ug/mL Roxithromycintranslation

-0.363

SM2-5 ug/mL Streptomycintranslation

0.207

Tet5-10 ug/mL Tetracyclinetranslation

0.956

Rif0.2-5ug/mL Rifampicintranscription

1.914

Rifp0.1-0.5ug/mL Rifapentinetranscription

1.787

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

2.184

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.039

CPZ10-50 ug/mL Chlorpromazinerespiration

0.715

Clofazimine10-13 ug/mL Clofaziminerespiration

0.066

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

2.453

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

2.591

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

1.483

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.042

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.150

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.521

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.863

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.308

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.600

KCN5-20 ug/mL Potassium cyaniderespiration

0.701

NaN30.2-2 mM Sodium aziderespiration

-0.562

Nigericin50 uM Nigericinrespiration

0.356

TRC10-150 ug/mL Triclosanrespiration

1.750

TRZ10-25 ug/mL Thioridazinerespiration

-1.493

Valinomycin0.5-10 uM Valinomycinrespiration

-0.557

ZnSO42 mM ZnSO4respiration

0.006

menadione6-10 ug/mL Menadionerespiration

-0.128

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.997

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.017

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.285

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.053

NRP_1Non-replicating persistence stage 1dosRassociated

-0.361

Amp0.2mg/mL AmpicillincellWall

-0.222

Cephalexin20-100 ug/mL CephalexincellWall

-0.798

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.545

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.133

EMB10-20 ug/mL EthambutolcellWall

-0.549

Eta12-40 ug/mL EthionamidecellWall

-0.459

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.033

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.714

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.010

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.269

BZA0.12 mg/mL BenzamidearomaticAmides

-0.359

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.882

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.291

H2O24 mM hydrogen peroxideDNAdamaging

0.551

Levo10 ug/mL LevofloxacinDNAdamaging

-0.688

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.756

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.485

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.749

UVUV-irradiationDNAdamaging

2.151

ARP41-4 ug/mL Antitubercular compound ARP4?

0.174

Antimycin12.5-50 ug/mL Antimycin A?

-0.100

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.183

PA_110-50 ug/mL Antitubercular compound PA-1?

0.185

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.500

PA8240.2-2 ug/mL PA-824?

0.109

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.056

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.573

Verapamil50 uM Verapamil?

0.746

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.257

methoxatin10-20 ug/mL Methoxatin?